| nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
| 1 |
A common 253-kb deletion involving VWF and TMEM16B in German and Italian patients with severe von Willebrand disease type 3
|
SCHNEPPENHEIM, R.
|
|
2007
|
5 |
4 |
p. 722-728
|
artikel
|
| 2 |
A cross-reactive material positive variant of coagulation factor XI (FXIP520L) with a catalytic defect
|
GAILANI, D.
|
|
2007
|
5 |
4 |
p. 781-787
|
artikel
|
| 3 |
A guide to murine coagulation factor structure, function, assays, and genetic alterations
|
EMEIS, J. J.
|
|
2007
|
5 |
4 |
p. 670-679
|
artikel
|
| 4 |
A guide to murine platelet structure, function, assays, and genetic alterations
|
JIROUSKOVA, M.
|
|
2007
|
5 |
4 |
p. 661-669
|
artikel
|
| 5 |
A mechanism to safeguard platelet adhesion under high shear flow: von Willebrand factor–glycoprotein Ib and integrin α2β1–collagen interactions make complementary, collagen-type-specific contributions to adhesion
|
MOROI, M.
|
|
2007
|
5 |
4 |
p. 797-803
|
artikel
|
| 6 |
ANNOUNCEMENTS
|
|
|
2007
|
5 |
4 |
p. 890-891
|
artikel
|
| 7 |
A phase II study of the oral factor Xa inhibitor LY517717 for the prevention of venous thromboembolism after hip or knee replacement
|
AGNELLI, G.
|
|
2007
|
5 |
4 |
p. 746-753
|
artikel
|
| 8 |
Characterization of endothelial-like cells derived from human mesenchymal stem cells
|
LIU, J. W.
|
|
2007
|
5 |
4 |
p. 826-834
|
artikel
|
| 9 |
Dietary supplement use among anticoagulation clinic patients
|
WITTKOWSKY, A. K.
|
|
2007
|
5 |
4 |
p. 875-877
|
artikel
|
| 10 |
Elevated plasma fibrinogen γ′ concentration is associated with myocardial infarction: effects of variation in fibrinogen genes and environmental factors
|
MANNILA, M. N.
|
|
2007
|
5 |
4 |
p. 766-773
|
artikel
|
| 11 |
ERRATUM
|
|
|
2007
|
5 |
4 |
p. 892
|
artikel
|
| 12 |
Ethnic differences in cardiovascular risk factors in healthy Caucasian and South Asian individuals with the metabolic syndrome
|
AJJAN, R.
|
|
2007
|
5 |
4 |
p. 754-760
|
artikel
|
| 13 |
Evaluation of the platelet response to clopidogrel with light transmittance aggregometry: peak aggregation or late aggregation?
|
VAN WERKUM, J. W.
|
|
2007
|
5 |
4 |
p. 884-886
|
artikel
|
| 14 |
Homozygosity for the C46T polymorphism of the F12 gene is a risk factor for venous thrombosis during the first pregnancy
|
COCHERY-NOUVELLON, É.
|
|
2007
|
5 |
4 |
p. 700-707
|
artikel
|
| 15 |
Hyperbilirubinemia interferes with ADAMTS-13 activity measurement by FRETS-VWF73 assay: diagnostic relevance in patients suffering from acute thrombotic microangiopathies
|
MEYER, S. C.
|
|
2007
|
5 |
4 |
p. 866-867
|
artikel
|
| 16 |
Identification of key residues involved in mediating the in vivo anti-tumor/anti-endothelial activity of Alphastatin
|
STATON, C. A.
|
|
2007
|
5 |
4 |
p. 846-854
|
artikel
|
| 17 |
Impact of plasma von Willebrand factor levels in the diagnosis of type 1 von Willebrand disease: results from a multicenter European study (MCMDM-1VWD)
|
TOSETTO, A.
|
|
2007
|
5 |
4 |
p. 715-721
|
artikel
|
| 18 |
Incidence and mortality of venous thrombosis: a population-based study
|
NÆSS, I. A.
|
|
2007
|
5 |
4 |
p. 692-699
|
artikel
|
| 19 |
Incidence of five prothrombotic gene polymorphisms in healthy Saudi Arabians
|
MAMMO, L.
|
|
2007
|
5 |
4 |
p. 877-878
|
artikel
|
| 20 |
Incidence of the JAK2 V617F mutation among patients with splanchnic or cerebral venous thrombosis and without overt chronic myeloproliferative disorders
|
DE STEFANO, V.
|
|
2007
|
5 |
4 |
p. 708-714
|
artikel
|
| 21 |
Increased platelet, leukocyte, and endothelial cell activity are associated with increased coagulability in patients after total knee arthroplasty
|
KAGEYAMA, K.
|
|
2007
|
5 |
4 |
p. 738-745
|
artikel
|
| 22 |
Indices of platelet activation and the stability of coronary artery disease
|
LINDEN, M. D.
|
|
2007
|
5 |
4 |
p. 761-765
|
artikel
|
| 23 |
Influence of the Thr325Ile polymorphism on procarboxypeptidase U (thrombin-activable fibrinolysis inhibitor) activity-based assays
|
WILLEMSE, J. L.
|
|
2007
|
5 |
4 |
p. 872-875
|
artikel
|
| 24 |
Insulin-like growth factor binding protein-3 induces angiogenesis through IGF-I- and SphK1-dependent mechanisms
|
GRANATA, R.
|
|
2007
|
5 |
4 |
p. 835-845
|
artikel
|
| 25 |
In vitro inhibition of thrombin generation, after tissue factor pathway activation, by the oral, direct factor Xa inhibitor rivaroxaban
|
GEROTZIAFAS, G. T.
|
|
2007
|
5 |
4 |
p. 886-888
|
artikel
|
| 26 |
JAK2 V617F is specifically associated with idiopathic splanchnic vein thrombosis
|
REGINA, S.
|
|
2007
|
5 |
4 |
p. 859-861
|
artikel
|
| 27 |
Neuroprotective effect of cilostazol against retinal ischemic damage via inhibition of leukocyte–endothelial cell interactions
|
IWAMA, D.
|
|
2007
|
5 |
4 |
p. 818-825
|
artikel
|
| 28 |
Plasma fibronectin levels and coronary artery disease
|
VAVALLE, J. P.
|
|
2007
|
5 |
4 |
p. 864-866
|
artikel
|
| 29 |
Preanalytical conditions that affect coagulation testing, including hormonal status and therapy
|
BLOMBÄCK, M.
|
|
2007
|
5 |
4 |
p. 855-858
|
artikel
|
| 30 |
Preferential localization of recombinant factor VIIa to platelets activated with a combination of thrombin and a glycoprotein VI receptor agonist
|
KJALKE, M.
|
|
2007
|
5 |
4 |
p. 774-780
|
artikel
|
| 31 |
Prognostic value of annexin A5 −1 C/T polymorphism in a long term follow-up after premature myocardial infarction
|
ROLDÁN, V.
|
|
2007
|
5 |
4 |
p. 862-863
|
artikel
|
| 32 |
Release of biologically active CD154 during collection and storage of platelet concentrates prepared for transfusion
|
KAUFMAN, J.
|
|
2007
|
5 |
4 |
p. 788-796
|
artikel
|
| 33 |
Standardization of circulating endothelial cell enumeration by the use of human umbilical vein endothelial cells
|
GOON, P. K. Y.
|
|
2007
|
5 |
4 |
p. 870-872
|
artikel
|
| 34 |
TAFIa, PAI-1 and α2-antiplasmin: complementary roles in regulating lysis of thrombi and plasma clots
|
MUTCH, N. J.
|
|
2007
|
5 |
4 |
p. 812-817
|
artikel
|
| 35 |
The effect of low-molecular-weight heparin on cancer survival. A systematic review and meta-analysis of randomized trials
|
LAZO-LANGNER, A.
|
|
2007
|
5 |
4 |
p. 729-737
|
artikel
|
| 36 |
The flow cytometric VASP assay can be used to determine the effectiveness of clopidogrel in patients treated with abciximab
|
VAN WERKUM, J. W.
|
|
2007
|
5 |
4 |
p. 881-883
|
artikel
|
| 37 |
The regulation by fibrinogen and fibrin of tissue plasminogen activator kinetics and inhibition by plasminogen activator inhibitor 1
|
THELWELL, C.
|
|
2007
|
5 |
4 |
p. 804-811
|
artikel
|
| 38 |
Ticlopidine could be an alternative therapy in the case of pharmacological resistance to clopidogrel: a report of three cases
|
ALEIL, B.
|
|
2007
|
5 |
4 |
p. 879-881
|
artikel
|
| 39 |
Venous thromboembolism and the concepts of the incidence and mortality
|
SØRENSEN, H. T.
|
|
2007
|
5 |
4 |
p. 690-691
|
artikel
|
| 40 |
von Willebrand factor collagen binding assay with a commercial kit using type III collagen in von Willebrand disease type 2
|
VEYRADIER, A.
|
|
2007
|
5 |
4 |
p. 868-870
|
artikel
|
Tijdschrift beschrijving